CD40LG and leprosy: In combination with classical detection of anti-PGL-I IgM antibodies, M. leprae peptide-based WBA measuring cytokines will not only allow detection of most forms of leprosy (PB and MB) but may also identify those at risk of developing disease by detecting preclinical forms of leprosy, thereby enabling installment of MDT at an early stage.